During the past decade, Tartu University Hospital Clinic of Hematology and Oncology conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 9 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tartu University Hospital Clinic of Hematology and Oncology" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Cancer International Research Group (CIRG)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German CLL Study Group" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Tartu University Hospital Clinic of Hematology and Oncology" are "Breast Cancer" (3 trials), "Advanced Cancer" (1 trials), "Breast Neoplasms" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Glioblastoma" (1 trials). Many other conditions were trialed in "Tartu University Hospital Clinic of Hematology and Oncology" in a lesser frequency.

Most popular intervention types in "Tartu University Hospital Clinic of Hematology and Oncology" are "Drug" (13 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (3 trials), "Docetaxel" (3 trials), "Placebo" (3 trials), "Trastuzumab" (3 trials) and "5-Fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tartu University Hospital Clinic of Hematology and Oncology" are 10 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Tartu University Hospital Clinic of Hematology and Oncology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Tartu University Hospital Clinic of Hematology and Oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Tartu University Hospital Clinic of Hematology and Oncology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".